PDT of Head and Neck Cancer

头颈癌PDT

• 批准号: 8230225
• 负责人: Nestor Rafael Rigual
• 金额: $ 42.53万
• 依托单位: ROSWELL PARK CANCER INSTITUTE CORP
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-02-01 至 2014-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8230225
• 关键词: Address; Biological Markers; Carcinoma in Situ; Cells; Clinical; Clinical Data; Clinical Management; Combined Modality Therapy; Databases; Deposition; Development; Dose; Effectiveness; Esophagus; Exhibits; Failure; Funding; Future; Generations; Goals; HPPH; Head and Neck Cancer; Head and Neck Squamous Cell Carcinoma; Human; In Vitro; Knowledge; Larynx; Lead; Light; Malignant Neoplasms; Malignant neoplasm of lung; Modality; Morbidity - disease rate; Mouth Carcinoma; Oral cavity; Outcome; Outpatients; Patients; Phase I Clinical Trials; Phenotype; Photochemotherapy; Photosensitivity; Photosensitization; Photosensitizing Agents; Porfimer Sodium; Pre-Clinical Model; Public Health; Recurrent tumor; Research Personnel; STAT3 gene; Safety; Sampling; Severe dysplasia; Signal Pathway; Sirolimus; Staging; Testing; The Sun; Tissue Sample; Tissues; Translations; Treatment outcome; Tumor Tissue; Up-Regulation; cell killing; crosslink; design; dosage; human FRAP1 protein; improved; larynx Carcinoma; minimally invasive; novel; outcome forecast; patient population; programs; response; standard care; success; treatment response; tumor

is needed,use Project/

需要，使用项目/